Therefore, our study provides an important contribution to explaining how NAMPT overexpression enhances tumor overall resistance to therapy, aggressive phenotype, and decreases patient survival (Sampath et al, 2015; Kennedy et al, 2016; Lucena-Cacace et al, 2018; Yaku et al, 2018). This evidence concerns the gene NAMPT and neoplasm.